We innovate for people SØMLØS was created to bridge the gap between man and machine. To enable humanity to focus more on the creative, complex, and beautiful aspects of life, and less on repetitive, everyday tasks. SØMLØS means "seamless" in norwergian. We want to offer smart robotics that can take over our repetitive, everyday tasks that takes up large sums of our lives. This way, we can focus our precious time on what really matters.

SocialScreen is a cloud-based digital signage software that lets you connect the data you already have. Combine it with the ease of creating new content and managing big fleets of screens! It works on any screen! SocialScreen works on all types of screens, TVs and devices. We have solutions for everyone, whether you want to set up a screen in the living room or need it for a large business. SocialScreen recommends the use of signage screens for professional use, as they are designed for constant use.

We have produced a unique app for fishing (so far in saltwater, Norway). After 6 weeks, we have been downloaded 85.000 times, in Norway. We combine the knowledge of the best fishermen in the country with AI, being a unique app for all types of fishing people. We combine 50 years of knowledge with cutting-edge technology, making the best fishing-app for everyone wanting to go fishing!

E24 er en del av Schibsted, og eies i fellesskap av VG, Aftenposten, Bergens Tidende og Stavanger Aftenblad. Med 1,5 millioner unike brukere hver uke, over halvparten på mobil, er vi Norges desidert største nettavis for økonomi og næringsliv. Høsten 2019 varslet vi en offensiv oppbemanning og nytt samarbeid på tvers i Schibsted, for å ta en enda sterkere og tyngre posisjon. Vi gir deg det aller siste fra aksjemarkedet, og tar pulsen på norsk og internasjonal økonomi, pluss nyheter fra felter som IT, ledelse, energi og bil.

SonoClear AS develops an acoustic contrast fluid to remove noise in ultrasound images, used during brain tumor surgery to guide tumor removal. The goal is to be sure that all tumor is removed, as total resection improves patient outcomes. The technology is developed by neurosurgeons at St.Olavs hospital and engineers at Sintef. The technology is patented worldwide and is developed as a medical device according to ISO13485. The core team consists of CTO, Medical advisor, Quality manager, and Regulatory officer. SonoClear plan for market access in USA and EU in 4q20 and 4q21, respectively.

BabySensor is developing a new unique monitor that measures the most important factors for a baby's health and well-being. It is the only product of its type monitoring heartbeat, temperature, lying position and baby’s cry. It is based on ground-breaking research and provides valuable information to parents through a mobile app. Safety is a high priority for families, and the trend shows a growing market within baby monitoring systems. We have a reliable, competent and experienced team who will succeed in turning the prototype into an attractive product.

Trollhetta is a software company offering solutions or added functionality to existing systems based on its proprietary development tools for machine vision, artificial intelligence and dynamic modelling. The company is now in the commercialization phase after several year with research and development. We are looking for a new manager in connection with going from the research and development phase to the commercialization phase.

Bygg- og anleggsbransjen er en lite digitalisert bransje per dags dato. NAEVA setter fokus på mer enn digitalisering. Vi ønsker i tillegg å effektivisere og automatisere hverdagen.Ved å kombinere de beste menneskene med nyskapende teknologi og innovative løsninger, ønsker vi å skape fremtidens bygg- og anleggsbransje i dag. Vi har vårt utgangspunkt i bygg- og anleggsbransjen, men våre løsninger kan skreddersys de fleste bransjer og industrier.

Det er stor konkurranse om de beste hodene i Norge, og det strekker desverre ikke til for alle de fantastiske idèene og bedriftene vi har.Outsourcing er sjeldent en god løsning da det bringer høy kompleksitet, lav utviklingshastighet og store sjanser for kommunikasjonsproblemer. Behovet for A-lags-spillere er høyt.Homesourcing finner fantastiske personer i Europa og integrerer de i norske utviklingsteam. Vi mener det finnes mer enn nok av utviklere i verden, men for få utviklere som også har lederevner. Vi coacher og bygger utviklere til ledere for å sørge for de blir like effektive som oss nordmenn og kan ta et større ansvar. Ikke minst kunne tenke selv og ta gode avgjørelser for teamene de er i.

FF Rollerskis AS – Bringing the Real Skiing Feeling to Asphalt FF Rollerskis AS is a Norwegian sports tech company redefining how athletes train off-season by designing and manufacturing world-leading roller skis. Founded by Henrik Lindhagen — skier, inventor, and innovator — our goal is simple: recreate the authentic feeling of skiing on snow, even on asphalt. Traditional roller skis are often stiff, unforgiving, and prone to cause strain or injury due to excessive vibration and poor flexibility. At FF Rollerskis, we’ve reengineered the roller ski from the ground up. Our unique floating fork suspension system and custom-developed rubber compounds drastically reduce vibration while preserving the natural flex and responsiveness of winter skis. The result? Roller skis that feel like the real thing. Our products include the FF V Pro Classic and FF Pro Skate, both equipped with V-groove wheels that enhance directional stability and simulate the resistance of groomed ski tracks. These wheels — along with advanced frame engineering — offer unparalleled ski feel, helping athletes maintain and refine technique throughout the off-season. Our Active series and Junior models make the FF experience accessible for younger athletes and recreational users alike. What sets FF Rollerskis apart: True ski feel on asphalt, with flex and vibration damping unmatched in the market. V-groove wheels that guide the ski naturally, improve control, and make skiing safer — especially for classic technique. Used by top athletes, including members of the Norwegian National Cross-Country Team and elite junior skiers. Only FIS-approved rollerski brand globally. Developed and tested in Norway — under real-world Nordic conditions. We’re committed to environmental responsibility and local production. All development and testing is done in Norway, and our goal is to bring the full manufacturing process home, enabling shorter supply chains, lower emissions, and job creation. Beyond just equipment, FF Rollerskis is building a movement. We offer a 100% satisfaction guarantee, provide free lifetime checkups (only pay for parts), and work closely with ambassadors and users to continuously improve our designs. Our customer base spans from beginners seeking safe, stable skis — to elite athletes demanding the highest performance. Whether you’re training for the World Cup, prepping for your first ski marathon, or looking for a smooth ride on summer roads, FF Rollerskis delivers the experience you’ve been missing. It’s not just about equipment — it’s about keeping the skiing spirit alive all year long. Visit us at www.ffskis.com Learn more: www.ffskis.com Learn more: ffskis.com Mail: henrik@ffskis.com Mobile: +47 95 88 70 70

UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

Medsensio will develop educational, clinical, and monitoring tools by analyzing medical data using machine learning and statistics. Our first project is developing an auscultation learning tool for students. Students will be able to verify their own interpretations of lung sounds using our machine-learning technology

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Gruten is an Oslo-based company that creates new value and meaning from coffee waste. We use coffee grounds in the production of soap and body scrub, and run an educational program with lectures, courses, and workshops to create awareness and knowledge about coffee grounds as a valuable resource.  We have a small production/workshop/outlet at Torshov, and sell our products on our own webshop + in ca 35 stores around Oslo and the rest of Norway. At the moment we are working hard to set up a site for mushroom production, growing oyster mushrooms on coffee grounds. When we get a go-ahead for this we will be in demand for funding to set up the production site (we will be growing in used cooling containers, so-called reefers) and need people to work on the site.

Vaskehjelp er en digital markedsplass som knytter kunder med renholdere i sitt nærområde. Vi er en fullfinansiert startup med solide eiere. Vi lanserte piloten i Trondheim 3.mars 2017 og har på 6 måneder 1000 bestilte oppdrag og 300 registrerte renholdere. Selskapet har brukt mye tid på å tilpasse systemet til norske lover og regler, slik at alle renholdere har en komplett leveranse via appen med full oversikt over økonomi og moms. Både kunde og renholder er forsikret og vi gjør all markedsføring. Det eneste renholderne selv må passe på er å betale sin egen skatt. Vaskehjelp er nå et team på fem personer som gjør seg klare for å skalere.